Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Clinical Pharmacist Intervention and Dapagliflozin as Add-On Therapy in the Management of Type 2 Diabetes Mellitus.

NCT06719661 is registered in ClinicalTrials.gov with University of Sulaimani as lead sponsor.

NCT NCT06719661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06719661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Clinical Pharmacist Intervention and Dapagliflozin as Add-On Therapy in the Management of Type 2 Diabetes Mellitus.
Lead sponsor
University of Sulaimani
Phase
Not applicable
Overall status
Completed
Start date
December 1, 2024
Completion date
June 1, 2025
Enrollment
138 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus (t2dm)